23948sdkhjf

Future drugs from Amaryllis

A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
A brand new research project from the Department of Pharmacy at the University of Copenhagen has proved that the Amaryllis plant contains substances that be used in the treatment aganst disease in the central nerve system, for example Alzheimer’s disease.

The active substance in, among others, Galanthamin, which can be extracted from snowdrops. It is already registred as a drug substance in Reminyl, used against dementia.

The research team has now recieved a EU grant of DKK 1,6 million to continue this research project and to, hopefully, find the base for new drugs in the future.

Kommentera en artikel
Meddela redaktionen
Medlemsnytt
Se alla medlemsnyheter
Mest läst
Senaste nytt
Se senaste nytt
Utvalda artiklar
Utvalda nyheter från förstasidan
Fritt fram sprida desinformation om covid-19 på Twitter
Outsourcing som strategi för ökad trovärdighet
Roche lägger ner utveckling av Alzheimerbehandling
Viss effekt av Alzheimers-behandling bekräftas i studie – Bioarctic stiger på börsen
Astra Zeneca köper immunterapibolaget Neogene i miljardaffär
Svensk export av läkemedel ökar kraftigt
Andra Nordiska Medier
Rent
MedTech Magazine
Recycling

Sänd till en kollega

0.096